These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30389682)

  • 1. PDX models recapitulate the genetic and epigenetic landscape of pediatric T-cell leukemia.
    Richter-Pechańska P; Kunz JB; Bornhauser B; von Knebel Doeberitz C; Rausch T; Erarslan-Uysal B; Assenov Y; Frismantas V; Marovca B; Waszak SM; Zimmermann M; Seemann J; Happich M; Stanulla M; Schrappe M; Cario G; Escherich G; Bakharevich K; Kirschner-Schwabe R; Eckert C; Muckenthaler MU; Korbel JO; Bourquin JP; Kulozik AE
    EMBO Mol Med; 2018 Dec; 10(12):. PubMed ID: 30389682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance.
    Nowak D; Liem NL; Mossner M; Klaumünzer M; Papa RA; Nowak V; Jann JC; Akagi T; Kawamata N; Okamoto R; Thoennissen NH; Kato M; Sanada M; Hofmann WK; Ogawa S; Marshall GM; Lock RB; Koeffler HP
    Exp Hematol; 2015 Jan; 43(1):32-43.e1-35. PubMed ID: 25450514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-derived xenotransplants can recapitulate the genetic driver landscape of acute leukemias.
    Wang K; Sanchez-Martin M; Wang X; Knapp KM; Koche R; Vu L; Nahas MK; He J; Hadler M; Stein EM; Tallman MS; Donahue AL; Frampton GM; Lipson D; Roels S; Stephens PJ; Sanford EM; Brennan T; Otto GA; Yelensky R; Miller VA; Kharas MG; Levine RL; Ferrando A; Armstrong SA; Krivtsov AV
    Leukemia; 2017 Jan; 31(1):151-158. PubMed ID: 27363283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human T-ALL Xenografts.
    Fuentes P; Toribio ML; González-García S
    Methods Mol Biol; 2021; 2185():215-239. PubMed ID: 33165851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse.
    Clappier E; Gerby B; Sigaux F; Delord M; Touzri F; Hernandez L; Ballerini P; Baruchel A; Pflumio F; Soulier J
    J Exp Med; 2011 Apr; 208(4):653-61. PubMed ID: 21464223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Speed of leukemia development and genetic diversity in xenograft models of T cell acute lymphoblastic leukemia.
    Poglio S; Lewandowski D; Calvo J; Caye A; Gros A; Laharanne E; Leblanc T; Landman-Parker J; Baruchel A; Soulier J; Ballerini P; Clappier E; Pflumio F
    Oncotarget; 2016 Jul; 7(27):41599-41611. PubMed ID: 27191650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PDX models reflect the proteome landscape of pediatric acute lymphoblastic leukemia but divert in select pathways.
    Uzozie AC; Ergin EK; Rolf N; Tsui J; Lorentzian A; Weng SSH; Nierves L; Smith TG; Lim CJ; Maxwell CA; Reid GSD; Lange PF
    J Exp Clin Cancer Res; 2021 Mar; 40(1):96. PubMed ID: 33722259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex genetic and histopathological study of 15 patient-derived xenografts of aggressive lymphomas.
    Jakša R; Karolová J; Svatoň M; Kazantsev D; Grajciarová M; Pokorná E; Tonar Z; Klánová M; Winkowska L; Maláriková D; Vočková P; Forsterová K; Renešová N; Dolníková A; Nožičková K; Dundr P; Froňková E; Trněný M; Klener P
    Lab Invest; 2022 Sep; 102(9):957-965. PubMed ID: 35488033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation.
    Kunz JB; Rausch T; Bandapalli OR; Eilers J; Pechanska P; Schuessele S; Assenov Y; Stütz AM; Kirschner-Schwabe R; Hof J; Eckert C; von Stackelberg A; Schrappe M; Stanulla M; Koehler R; Avigad S; Elitzur S; Handgretinger R; Benes V; Weischenfeldt J; Korbel JO; Muckenthaler MU; Kulozik AE
    Haematologica; 2015 Nov; 100(11):1442-50. PubMed ID: 26294725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cross-standardized flow cytometry platform to assess phenotypic stability in precursor B-cell acute lymphoblastic leukemia (B-ALL) xenografts.
    Rolf N; Liu LYT; Tsang A; Lange PF; Lim CJ; Maxwell CA; Vercauteren SM; Reid GSD
    Cytometry A; 2022 Jan; 101(1):57-71. PubMed ID: 34128309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast tumor PDXs are genetically plastic and correspond to a subset of aggressive cancers prone to relapse.
    du Manoir S; Orsetti B; Bras-Gonçalves R; Nguyen TT; Lasorsa L; Boissière F; Massemin B; Colombo PE; Bibeau F; Jacot W; Theillet C
    Mol Oncol; 2014 Mar; 8(2):431-43. PubMed ID: 24394560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of patient-specific features of altered DNA replication timing in xenografts of primary human acute lymphoblastic leukemia.
    Sasaki T; Rivera-Mulia JC; Vera D; Zimmerman J; Das S; Padget M; Nakamichi N; Chang BH; Tyner J; Druker BJ; Weng AP; Civin CI; Eaves CJ; Gilbert DM
    Exp Hematol; 2017 Jul; 51():71-82.e3. PubMed ID: 28433605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The first Japanese biobank of patient-derived pediatric acute lymphoblastic leukemia xenograft models.
    Tanaka K; Kato I; Dobashi Y; Imai JI; Mikami T; Kubota H; Ueno H; Ito M; Ogawa S; Nakahata T; Takita J; Toyoda H; Ogawa C; Adachi S; Watanabe S; Goto H
    Cancer Sci; 2022 Nov; 113(11):3814-3825. PubMed ID: 35879192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
    Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
    Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian carcinoma patient derived xenografts reproduce their tumor of origin and preserve an oligoclonal structure.
    Colombo PE; du Manoir S; Orsett B; Bras-Gonçalves R; Lambros MB; MacKay A; Nguyen TT; Boissière F; Pourquier D; Bibeau F; Reis-Filho JS; Theillet C
    Oncotarget; 2015 Sep; 6(29):28327-40. PubMed ID: 26334103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corruption of neuroblastoma patient derived xenografts with human T cell lymphoma.
    Williams AP; Stewart JE; Stafman LL; Aye JM; Mroczek-Musulman E; Ren C; Yoon K; Whelan K; Beierle EA
    J Pediatr Surg; 2019 Oct; 54(10):2117-2119. PubMed ID: 30391152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.
    Wang D; Pham NA; Tong J; Sakashita S; Allo G; Kim L; Yanagawa N; Raghavan V; Wei Y; To C; Trinh QM; Starmans MH; Chan-Seng-Yue MA; Chadwick D; Li L; Zhu CQ; Liu N; Li M; Lee S; Ignatchenko V; Strumpf D; Taylor P; Moghal N; Liu G; Boutros PC; Kislinger T; Pintilie M; Jurisica I; Shepherd FA; McPherson JD; Muthuswamy L; Moran MF; Tsao MS
    Int J Cancer; 2017 Feb; 140(3):662-673. PubMed ID: 27750381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR4 Is Required for Leukemia-Initiating Cell Activity in T Cell Acute Lymphoblastic Leukemia.
    Passaro D; Irigoyen M; Catherinet C; Gachet S; Da Costa De Jesus C; Lasgi C; Tran Quang C; Ghysdael J
    Cancer Cell; 2015 Jun; 27(6):769-79. PubMed ID: 26058076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide analyses identify KLF4 as an important negative regulator in T-cell acute lymphoblastic leukemia through directly inhibiting T-cell associated genes.
    Li W; Jiang Z; Li T; Wei X; Zheng Y; Wu D; Yang L; Chen S; Xu B; Zhong M; Jiang J; Hu Y; Su H; Zhang M; Huang X; Geng S; Weng J; Du X; Liu P; Li Y; Liu H; Yao Y; Li P
    Mol Cancer; 2015 Feb; 14():26. PubMed ID: 25644173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in Stratifying the Molecular Variability of Patient-Derived Colon Tumor Xenografts.
    Cybulska M; Olesinski T; Goryca K; Paczkowska K; Statkiewicz M; Kopczynski M; Grochowska A; Unrug-Bielawska K; Tyl-Bielicka A; Gajewska M; Mroz A; Dabrowska M; Karczmarski J; Paziewska A; Zając L; Bednarczyk M; Mikula M; Ostrowski J
    Biomed Res Int; 2018; 2018():2954208. PubMed ID: 30662905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.